INS and Insulin resistance: Similarly, treatment of HF-fed wild-type mice with exenatide, a long-acting glucagon-like peptide-1 receptor agonist that stimulates insulin secretion, prevented diet-induced insulin resistance and altered metabolism by restoring hepatic CEACAM1 expression via a PPARγ-dependent pathway [137].